NYSE:EWMedical Equipment
A Look At Edwards Lifesciences (EW) Valuation As It Exits Critical Care To Focus On Core Heart Therapies
Edwards Lifesciences (EW) has been back in focus after moving to sell its critical care unit and to concentrate on areas such as asymptomatic aortic stenosis and structural heart failure, along with fresh Q4 numbers.
See our latest analysis for Edwards Lifesciences.
The recent decision to sell the critical care unit, Q4 results, and the appointment of a new Director of Government Affairs have all come as Edwards Lifesciences posts a 10.79% 1 month share price return and a 24.20% 1 year total...